| PERIOD ENDING | 3-Oct-09 | 4-Jul-09 | 4-Apr-09 | 3-Jan-09 | | Total Revenue | 87,917 | 92,059 | 89,466 | 85,674 | | Cost of Revenue | 34,185 | 41,304 | 35,439 | 35,106 | | | Gross Profit | 53,732 | 50,755 | 54,027 | 50,568 | | | Operating Expenses | | Research Development | 13,350 | 13,426 | 14,086 | 14,142 | | Selling General and Administrative | 24,226 | 30,776 | 27,455 | 25,804 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 2,568 | 2,568 | 2,931 | 3,296 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 13,588 | 3,985 | 9,555 | 7,326 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 7,134 | 1,637 | 988 | 2,504 | | Earnings Before Interest And Taxes | 20,722 | 5,622 | 10,543 | 9,830 | | Interest Expense | 3,261 | 3,040 | 2,866 | 1,009 | | Income Before Tax | 17,461 | 2,582 | 7,677 | 8,821 | | Income Tax Expense | 5,683 | 750 | 2,050 | 2,471 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,778 | 1,832 | 5,627 | 6,350 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,778 | 1,832 | 5,627 | 6,350 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,778 | $1,832 | $5,627 | $6,350 |
|
0.42% Nasdaq 
Income Statement
